Insulet
PODD
#1320
Rank
NZ$28.30 B
Marketcap
NZ$402.15
Share price
-0.89%
Change (1 day)
-3.13%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - P/B ratio

P/B ratio as of March 2026 : 12.1

According to Insulet's latest financial reports the company has a price-to-book ratio of 6.65019.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Insulet - P/B ratio (from 2007 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-3114.4-6.27%
2024-12-3115.3-25.77%
2023-12-3120.7-51.82%
2022-12-3142.930.1%
2021-12-3133.018.14%
2020-12-3127.9-80.25%
2019-12-31141538.77%
2018-12-3122.1-12.61%
2017-12-3125.3-26.08%
2016-12-3134.3-45.82%
2015-12-3163.2104.45%
2014-12-3130.989.33%
2013-12-3116.3-29.67%
2012-12-3123.2115.35%
2011-12-3110.81.43%
2010-12-3110.64.26%
2009-12-3110.244.87%
2008-12-317.047.95%
2007-12-316.52
2006-12-31N/A
2005-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.20-40.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.75-69.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
2.36-80.50%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
33.8 178.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
11.2-7.20%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
1.54-87.31%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
9.63-20.53%๐Ÿ‡บ๐Ÿ‡ธ USA